Fundraising Fox
Deciphex
Founded 2017 · 183 employees on LinkedIn · 10 known investors
Find your way into Deciphex
Sign up to see every warm intro you have to Deciphex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deciphex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists. The company serves pathologists, pharmaceutical companies, and healthcare systems to improve diagnostic accuracy and drug development outcomes.
Investors · 10
How we know: Act Venture Capital's portfolio page · Not right? Tell us
How we know: ACT Venture Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Claret Capital Partners's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Molten Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountVenture Debt FundingOct 2025Source ↗
- Undisclosed amountSeries CJan 2025Source ↗
- Undisclosed amountSeries BMay 2022
ACT Venture Capital (lead), Charles River Laboratories, HBAN Medtech Syndicate, IRRUS Investments, Nextsteps Capital, Novartis
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Deciphex do?
- Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists. The company serves pathologists, pharmaceutical companies, and healthcare systems to improve diagnostic accuracy and drug development outcomes.
- Who are Deciphex's investors?
- Deciphex's investors include Act Venture Capital, ACT Venture Capital, Claret Capital Partners, Molten Ventures, Seroba Life Sciences.